Home/Filings/4/0001209191-12-021515
4//SEC Filing

Holveck David 4

Accession 0001209191-12-021515

CIK 0001100962other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 5:39 PM ET

Size

9.4 KB

Accession

0001209191-12-021515

Insider Transaction Report

Form 4
Period: 2012-04-01
Holveck David
DirectorPresident & CEO
Transactions
  • Tax Payment

    Common Stock, par value, $0.01 per share

    2012-04-01$38.94/sh2,599$101,2053,803 total
Footnotes (3)
  • [F1]13.89% of Mr. Holveck's April 1, 2008 grant of restricted stock units (RSUs) vested on April 1, 2012. Upon vesting, certain shares are withheld by the issuer to satisfy tax obligations on shares acquired.
  • [F2]These shares represent stock withheld by the issuer to satisfy tax withholding obligations on shares acquired upon vesting of restricted stock units.
  • [F3]$38.94 represents the average of the high and low share price on March 30, 2012 (since April 1, 2012 was a Sunday).

Issuer

ENDO PHARMACEUTICALS HOLDINGS INC

CIK 0001100962

Entity typeother

Related Parties

1
  • filerCIK 0001429993

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 5:39 PM ET
Size
9.4 KB